Variant report
Variant | esv3425744 |
---|---|
Chromosome Location | chr2:127231632-127233780 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:127219083..127220899-chr2:127231982..127233485,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs145610735 | chr2:127232804-127232805 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs564314910 | chr2:127232807-127232808 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs367952348 | chr2:127232858-127232859 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs533136249 | chr2:127232875-127232876 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs55940613 | chr2:127232891-127232892 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs562582833 | chr2:127232892-127232893 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs113241567 | chr2:127232939-127232940 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs541945105 | chr2:127232972-127232973 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs77504579 | chr2:127232982-127232983 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs548136611 | chr2:127232983-127232984 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs184566765 | chr2:127233015-127233016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs148489423 | chr2:127233021-127233022 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs547474507 | chr2:127233058-127233059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs570988908 | chr2:127233078-127233079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs115102962 | chr2:127233091-127233092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs12996594 | chr2:127233114-127233115 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs576638700 | chr2:127233149-127233150 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs190197426 | chr2:127233151-127233152 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs568465873 | chr2:127233157-127233158 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs182359237 | chr2:127233167-127233168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs548025395 | chr2:127233199-127233200 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs185107683 | chr2:127233200-127233201 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs75171600 | chr2:127233205-127233206 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs564149969 | chr2:127233237-127233238 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs577785088 | chr2:127233248-127233249 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs142509607 | chr2:127233290-127233291 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs563443938 | chr2:127233365-127233366 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs77862562 | chr2:127233407-127233408 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs548859809 | chr2:127233427-127233428 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs147573153 | chr2:127233438-127233439 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs79166072 | chr2:127233442-127233443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs78142377 | chr2:127233446-127233447 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs181713957 | chr2:127233447-127233448 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs147723896 | chr2:127233452-127233453 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs368160937 | chr2:127233458-127233459 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs117898503 | chr2:127233489-127233490 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs75102187 | chr2:127233512-127233513 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs548382413 | chr2:127233517-127233518 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs145841611 | chr2:127233534-127233535 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs147801943 | chr2:127233562-127233563 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs715915 | chr2:127233566-127233567 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs534574748 | chr2:127233589-127233590 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs557900222 | chr2:127233603-127233604 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs568219540 | chr2:127233702-127233703 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs75122292 | chr2:127233703-127233704 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs553992311 | chr2:127233712-127233713 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs76680335 | chr2:127233720-127233721 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Mental retardation | 17621639 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neurocytoma | 17123091 | CNVD |
Developmental delay | 21147756 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:127232800-127233200 | Enhancers | Fetal Brain Male | brain |
2 | chr2:127232800-127233400 | Enhancers | Fetal Heart | heart |
3 | chr2:127233200-127235400 | Weak transcription | Fetal Brain Male | brain |